The burden of infant group B streptococcal infections in Ontario: Analysis of administrative data to estimate the potential benefits of new vaccines
Group B streptococcus (GBS) is a leading bacterial cause of neonatal sepsis and meningitis in many countries as well as an important cause of disease in pregnant women. Currently, serotype-specific conjugate vaccines are being developed. We conducted an epidemiological analysis of health administrat...
Main Authors: | James Hartley, Ye Li, Liz Kunkel, Natasha S. Crowcroft |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1511666 |
Similar Items
-
Strategies to Prevent Early and Late-Onset Group B <i>Streptococcal</i> Infection via Interventions in Pregnancy
by: Mahin Delara, et al.
Published: (2023-02-01) -
Exploring the Feasibility of Intrapartum GBS Collection to Identify Residual GBS in a Pilot Study of an Antenatal Probiotic Intervention
by: Emily Malloy, et al.
Published: (2023-07-01) -
Late-Onset Sepsis in a Premature Infant Mediated by Breast Milk: Mother-to-Infant Transmission of Group B Streptococcus Detected by Whole-Genome Sequencing
by: Li A, et al.
Published: (2022-09-01) -
Etiological serotype and genotype distributions and clinical characteristics of group B streptococcus-inducing invasive disease among infants in South China
by: Yao Zhu, et al.
Published: (2020-04-01) -
The Peculiarity of Infection and Immunity Correlated with Guillain-Barré Syndrome in the HIV-Infected Population
by: Yanli Wang, et al.
Published: (2023-01-01)